Periodontitis
Conditions
Keywords
periodontitis, full mouth scaling, air abrasion, scaling
Brief summary
It is the aim of the study to evaluate the efficiency of One stage full mouth disinfection according to the original protocol (Quirynen et al. 1995) in comparison to other approaches considering different scaling strategies and different disinfection concepts. Therefore, a multicenter randomized control treatment will be performed. In total, 204 patients with chronic periodontitis shall be allocated to the following treatment concepts. Group A: quadrant scaling with weekly intervals (Q-SRP; N = 51); Group B: full mouth scaling (FMS; N = 51); Group C: full mouth disinfection (FMD; N = 51); Group D: full mouth disinfection with subgingival glycine air polishing using erythritol powder (FMDP; N = 51). Evaluation of periodontopathic parameters and periodontal pathogens at baseline, 3 months and 6 months shall give evidence about the benefits of concept and the single components of FMD.
Interventions
Quadrant scaling and root planing under local anesthesia using ultrasonic devices (Piezon-Master, EMS) and Gracey curettes (Hu-Friedy) within four sessions in intervals of 1 week
Full mouth scaling and rootplaning under local anesthesia using ultrasonic devices (Piezon-Master, EMS) and Gracey curettes (Hu-Friedy) within 24 hours
Full mouth scaling and rootplaning under local anesthesia using ultrasonic devices (Piezon-Master, EMS) and Gracey curettes (Hu-Friedy) within 24 hours with additional disinfection using 0.2% chlorhexidine (mouth rinsing and tonsil spray), subgingival application of 1% chlorhexidine gel and 2 months postoperative home care using chlorhexidine 0.2% (rinse and spray)
FMD protocol (see FMD arm) with additional use of subgingival airpolishing (Air Flow, EMS) using Erythritol powder (Air-Flow Plus powder, EMS) for 20 seconds per tooth
Sponsors
Study design
Masking description
The examiner performing the measurement of all clinical periodontal parameters is not aware of the type of treatment provided to the patient.
Intervention model description
multicenter randomized controlled intervention trial
Eligibility
Inclusion criteria
* patients with generalized moderate to severe chronic periodontitis * presence of at least 18 teeth * with at least 2 multi-rooted and / or 2 single-rooted teeth in the first quadrant with at least 6 sites with periodontal probing depth of ≥ 6 mm * radiographic bone loss of at least 25% of the root length
Exclusion criteria
* subgingival scaling and root planing within the last 12 months * antimicrobial rinsing or intake of systemic antibiotics within the last 4 months * systemic diseases with known interactions to periodontal disease or known need for antibiotic prophylaxis * known intolerance / allergies to chlorhexidine * pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of clinical attachment level | Baseline, 3 months, 6 months | Measuring the change of the distance between the cemento-enamel junction and the bottom of the periodontal pocket 3 and 6 months after therapy compared to baseline |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of pocket probing depth | Baseline, 3 months, 6 months | Measuring the change of the distance between the gingival sulcus and the bottom of the periodontal pocket 3 and 6 months after therapy compared to baseline |
| Change of presence of periodontopathogenic bacteria A. actinomycetemcomitans, P. gingivalis, P. intermedia and T. denticola | Baseline, 3 months, 6 months | Analysis of pooled subgingival plaque specimen for the presence of periodontopathogenic marker bacteria A. actinomycetemcomitans, P. gingivitis, T. forsythia and P. intermedia; Assessment of the change of the occurrence of these bacteria 3 and 6 months after therapy compared to baseline |
| Change of bleeding on probing | Baseline, 3 months, 6 months | Assessment of the change of the appearance of a bleeding spot immediately after the probing of periodontal pockets 3 and 6 months after therapy compared to baseline |
| Change of gingival index | Baseline, 3 months, 6 months | Recording the change of the presence of supragingival plaque according to the criteria by assessment of the inflammatory status of the gingiva according to Löe et al. 3 and 6 months after therapy compared to baseline |
| Change of plaque index | Baseline, 3 months, 6 months | Recording the change of the presence of supragingival plaque according to the criteria by Silness and Loe 3 and 6 months after therapy compared to baseline |
Countries
Germany, Romania